SJS Investment Consulting’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTC
IAM
SJS Investment Consulting's BNTC Position: Q3 2026 in Review
SJS Investment Consulting increased its Benitec Biopharma (BNTC) stake by 800% in Q3 2026, buying an estimated $196 and bringing the position to 18 shares worth $180. The position accounts for ﹤0.01% of the portfolio, ranked #2967.
SJS Investment Consulting first reported a position in BNTC in Q2 2026 and has held it in 2 quarters since. 91 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.
- SJS Investment Consulting held 18 shares of Benitec Biopharma worth $180 as of Q3 2026.
- SJS Investment Consulting bought 16 Benitec Biopharma shares in Q3 2026, an estimated $196.
- Benitec Biopharma made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2967 holding.
- SJS Investment Consulting first reported a position in Benitec Biopharma in Q2 2026 and has held it in 2 quarters since.
- 91 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.